Neurable Open for Business: Scaling Neurotechnology Adoption Through Global OEM Integration
Summary
Neurable announced a $35 million Series A led by Spectrum Moonshot Fund in December 2025, bringing total funding to $65M. The funding accelerates commercialization of Neurable AI — the company's patented compact brain-signal processing technology that integrates BCI into everyday devices. Their MW75 Neuro LT headphones provide real-time cognitive insights on mental fatigue, recovery, and focus. At CES 2026, Neurable and HyperX (HP gaming) received Best of Show recognition for their BCI gaming headset. In April 2026, Neurable announced a licensing platform model allowing global OEM partners to embed its brain-sensing tech into headphones, AR glasses, hats, and headbands — targeting 5 OEM launches between 2026 and 2028. CEO Ramses Alcaide described the strategy as an "Intel Inside" model for brain-sensing in consumer devices.
Why it matters
Neurable's OEM licensing pivot is the most strategically significant consumer BCI move since Neurosity launched the Crown. Rather than competing to sell their own hardware, Neurable is becoming the brain-sensing layer inside devices people already buy — the same business model that made Qualcomm dominant in mobile. Five global OEM deals would put Neurable's EEG AI inside tens of millions of consumer devices without Neurable needing to manufacture any of them.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trial